vs

Side-by-side financial comparison of ADC Therapeutics SA (ADCT) and ESPEY MFG & ELECTRONICS CORP (ESP). Click either name above to swap in a different company.

ADC Therapeutics SA is the larger business by last-quarter revenue ($23.1M vs $12.1M, roughly 1.9× ESPEY MFG & ELECTRONICS CORP). On growth, ADC Therapeutics SA posted the faster year-over-year revenue change (36.4% vs -10.8%). Over the past eight quarters, ESPEY MFG & ELECTRONICS CORP's revenue compounded faster (21.3% CAGR vs 13.7%).

ADC Telecommunications, Inc. was a communications company in Eden Prairie, Minnesota, a southwest suburb of Minneapolis. It was acquired by TE Connectivity in December 2010 and ceased to exist as a separate entity. ADC products were sold by CommScope after it acquired the Broadband Network Solutions business unit from TE Connectivity in August 2015.

ESPEY MFG & ELECTRONICS CORP is a US-based manufacturer specializing in high-reliability power supplies, power conversion systems and specialized electronic components. It serves aerospace, defense, industrial and transportation sectors, delivering custom solutions for harsh environments to OEMs and government contractors across North America and select global markets.

ADCT vs ESP — Head-to-Head

Bigger by revenue
ADCT
ADCT
1.9× larger
ADCT
$23.1M
$12.1M
ESP
Growing faster (revenue YoY)
ADCT
ADCT
+47.2% gap
ADCT
36.4%
-10.8%
ESP
Faster 2-yr revenue CAGR
ESP
ESP
Annualised
ESP
21.3%
13.7%
ADCT

Income Statement — Q4 FY2025 vs Q2 FY2026

Metric
ADCT
ADCT
ESP
ESP
Revenue
$23.1M
$12.1M
Net Profit
$2.8M
Gross Margin
34.7%
Operating Margin
-77.7%
25.3%
Net Margin
23.1%
Revenue YoY
36.4%
-10.8%
Net Profit YoY
47.0%
EPS (diluted)
$0.04
$0.99

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ADCT
ADCT
ESP
ESP
Q4 25
$23.1M
$12.1M
Q3 25
$15.8M
$9.1M
Q2 25
$18.1M
$9.6M
Q1 25
$17.4M
$10.3M
Q4 24
$16.9M
$13.6M
Q3 24
$18.0M
$10.4M
Q2 24
$17.0M
$11.6M
Q1 24
$17.8M
$8.3M
Net Profit
ADCT
ADCT
ESP
ESP
Q4 25
$2.8M
Q3 25
$-41.0M
$2.2M
Q2 25
$-56.6M
$2.9M
Q1 25
$-38.6M
$1.7M
Q4 24
$1.9M
Q3 24
$-44.0M
$1.6M
Q2 24
$-36.5M
$1.9M
Q1 24
$-46.6M
$1.0M
Gross Margin
ADCT
ADCT
ESP
ESP
Q4 25
34.7%
Q3 25
35.4%
Q2 25
39.3%
Q1 25
28.6%
Q4 24
23.2%
Q3 24
26.8%
Q2 24
27.6%
Q1 24
25.0%
Operating Margin
ADCT
ADCT
ESP
ESP
Q4 25
-77.7%
25.3%
Q3 25
-196.6%
22.7%
Q2 25
-244.1%
27.4%
Q1 25
-163.5%
17.0%
Q4 24
-191.8%
14.9%
Q3 24
-197.4%
16.5%
Q2 24
-170.5%
18.4%
Q1 24
-188.3%
13.2%
Net Margin
ADCT
ADCT
ESP
ESP
Q4 25
23.1%
Q3 25
-260.1%
23.9%
Q2 25
-313.2%
30.6%
Q1 25
-221.8%
16.5%
Q4 24
14.0%
Q3 24
-244.1%
15.3%
Q2 24
-214.6%
16.3%
Q1 24
-261.1%
12.5%
EPS (diluted)
ADCT
ADCT
ESP
ESP
Q4 25
$0.04
$0.99
Q3 25
$-0.30
$0.76
Q2 25
$-0.50
$1.07
Q1 25
$-0.36
$0.63
Q4 24
$-0.26
$0.71
Q3 24
$-0.42
$0.61
Q2 24
$-0.38
$0.73
Q1 24
$-0.56
$0.40

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ADCT
ADCT
ESP
ESP
Cash + ST InvestmentsLiquidity on hand
$261.3M
$17.8M
Total DebtLower is stronger
Stockholders' EquityBook value
$-185.8M
$53.2M
Total Assets
$323.1M
$85.2M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ADCT
ADCT
ESP
ESP
Q4 25
$261.3M
$17.8M
Q3 25
$234.7M
$22.2M
Q2 25
$264.6M
$18.9M
Q1 25
$194.7M
$13.9M
Q4 24
$250.9M
$8.0M
Q3 24
$274.3M
$4.8M
Q2 24
$300.1M
$4.4M
Q1 24
$234.3M
$5.6M
Stockholders' Equity
ADCT
ADCT
ESP
ESP
Q4 25
$-185.8M
$53.2M
Q3 25
$-238.2M
$51.0M
Q2 25
$-199.2M
$50.8M
Q1 25
$-238.2M
$46.3M
Q4 24
$-202.6M
$44.8M
Q3 24
$-171.9M
$42.5M
Q2 24
$-131.7M
$41.3M
Q1 24
$-194.4M
$39.3M
Total Assets
ADCT
ADCT
ESP
ESP
Q4 25
$323.1M
$85.2M
Q3 25
$289.8M
$84.8M
Q2 25
$321.6M
$79.1M
Q1 25
$272.5M
$72.8M
Q4 24
$322.0M
$60.2M
Q3 24
$349.1M
$57.6M
Q2 24
$371.8M
$56.5M
Q1 24
$308.0M
$53.1M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ADCT
ADCT
ESP
ESP
Operating Cash FlowLast quarter
$-31.1M
$-2.8M
Free Cash FlowOCF − Capex
$-4.1M
FCF MarginFCF / Revenue
-34.1%
Capex IntensityCapex / Revenue
0.0%
10.9%
Cash ConversionOCF / Net Profit
-1.00×
TTM Free Cash FlowTrailing 4 quarters
$11.7M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ADCT
ADCT
ESP
ESP
Q4 25
$-31.1M
$-2.8M
Q3 25
$-29.6M
$5.7M
Q2 25
$-24.1M
$2.8M
Q1 25
$-56.3M
$11.5M
Q4 24
$-21.9M
$5.4M
Q3 24
$-25.0M
$1.4M
Q2 24
$-32.8M
$3.2M
Q1 24
$-44.1M
$1.4M
Free Cash Flow
ADCT
ADCT
ESP
ESP
Q4 25
$-4.1M
Q3 25
$4.4M
Q2 25
$915.3K
Q1 25
$-56.6M
$10.5M
Q4 24
$-21.9M
$4.5M
Q3 24
$-25.3M
$724.8K
Q2 24
$-32.9M
$2.6M
Q1 24
$-44.6M
$379.1K
FCF Margin
ADCT
ADCT
ESP
ESP
Q4 25
-34.1%
Q3 25
48.7%
Q2 25
9.5%
Q1 25
-325.2%
101.8%
Q4 24
-129.8%
33.0%
Q3 24
-140.2%
6.9%
Q2 24
-193.0%
22.2%
Q1 24
-250.0%
4.6%
Capex Intensity
ADCT
ADCT
ESP
ESP
Q4 25
0.0%
10.9%
Q3 25
0.0%
14.2%
Q2 25
0.0%
19.3%
Q1 25
1.5%
9.3%
Q4 24
0.5%
6.5%
Q3 24
1.2%
6.4%
Q2 24
0.2%
5.7%
Q1 24
3.0%
12.5%
Cash Conversion
ADCT
ADCT
ESP
ESP
Q4 25
-1.00×
Q3 25
2.64×
Q2 25
0.95×
Q1 25
6.72×
Q4 24
2.82×
Q3 24
0.87×
Q2 24
1.71×
Q1 24
1.37×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ADCT
ADCT

Segment breakdown not available.

ESP
ESP

ASC606$11.3M93%
Other$855.0K7%

Related Comparisons